Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Pharmaceutical companies require extensive genomic data to effectively implement precision medicine initiatives; however, they frequently rely on merely 10% of the available information for their decisions. Genomenon provides access to the complete dataset. Their Prodigy™ Patient Landscapes offer a streamlined and economical solution for natural history research, aiding the creation of therapies for rare diseases by deepening understanding of both retrospective and prospective health data. Utilizing an advanced AI-driven methodology, Genomenon conducts a thorough evaluation of each patient documented in the medical literature in a significantly reduced timeframe. Ensure you capture all relevant insights by exploring every genomic biomarker featured in published studies. Each scientific claim is substantiated by concrete evidence drawn from the medical literature, allowing researchers to uncover all genetic drivers and identify variants recognized as pathogenic in accordance with ACMG clinical standards, thereby enhancing the development process of targeted therapies. By leveraging this comprehensive approach, pharma companies can enhance their research effectiveness and ultimately improve patient outcomes.

Description

Each day, a diverse group of healthcare professionals including nurses, doctors, students, professors, and administrators turn to Ovid for the latest research, which encompasses contributions from more than 120 publishers and spans over 100 specialized fields. The New England Journal of Medicine (NEJM), recognized for its commitment to delivering exceptional research and vital information to clinical practice, serves as an invaluable resource for physicians by ensuring they remain current on advancements that affect their patients' care. A thorough peer-review and editing process is employed to assess manuscripts, guaranteeing their scientific validity, innovation, and significance. Available on Ovid®, NEJM showcases groundbreaking research, clinical perspectives, and medical advancements across more than 125 disciplines, all offered through a respected platform renowned for medical research. Additionally, the Ovid® Synthesis Clinical Evidence Manager provides a user-friendly cloud-based solution, boasting unmatched capabilities for literature search and review, further enhancing the research experience for healthcare professionals. This combination of resources empowers practitioners to stay informed and improves patient outcomes through evidence-based care.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

Google Cloud Platform

Integrations

Google Cloud Platform

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

Genomenon

Country

United States

Website

www.genomenon.com/pharma/

Vendor Details

Company Name

Wolters Kluwer

Country

United States

Website

www.wolterskluwer.com/en/solutions/ovid

Product Features

Alternatives

Alternatives

VSClinical Reviews

VSClinical

Golden Helix
Scopus Reviews

Scopus

Elsevier
MEDLINE Reviews

MEDLINE

National Library of Medicine